These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 21045798)

  • 1. Use of botulinum toxin in the neurology clinic.
    Lim EC; Seet RC
    Nat Rev Neurol; 2010 Nov; 6(11):624-36. PubMed ID: 21045798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients.
    Pullman SL; Greene P; Fahn S; Pedersen SF
    Arch Neurol; 1996 Jul; 53(7):617-24. PubMed ID: 8929169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin: State of the art.
    Jankovic J
    Mov Disord; 2017 Aug; 32(8):1131-1138. PubMed ID: 28639368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of botulinum neurotoxin therapy].
    Mukai Y; Kaji R
    Brain Nerve; 2011 Jul; 63(7):775-84. PubMed ID: 21747148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Other uses for botulinum toxin in neurology].
    Vial C; Bouhour F; de Saint Victor JF
    Rev Neurol (Paris); 2003 Sep; 159(8-9):814-8. PubMed ID: 13679728
    [No Abstract]   [Full Text] [Related]  

  • 6. Botulinum toxin injection, dilution confusion: The impact of toxin diffusion on clinical practice.
    Davis T
    J Pediatr Rehabil Med; 2020; 13(2):201-204. PubMed ID: 32568126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin: a dreaded toxin for use in human being.
    Ghosh B; Das SK
    J Indian Med Assoc; 2002 Oct; 100(10):607-8, 610-2, 614. PubMed ID: 12452515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Update on Botulinum Toxin in Neurology.
    Chiu SY; Burns MR; Malaty IA
    Neurol Clin; 2021 Feb; 39(1):209-229. PubMed ID: 33223084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin.
    Marion MH; Humberstone M; Grunewald R; Wimalaratna S
    Pract Neurol; 2016 Aug; 16(4):288-95. PubMed ID: 26976927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International consensus statement for the use of botulinum toxin treatment in adults and children with neurological impairments--introduction.
    Esquenazi A; Novak I; Sheean G; Singer BJ; Ward AB
    Eur J Neurol; 2010 Aug; 17 Suppl 2():1-8. PubMed ID: 20633176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin.
    Koman LA; Paterson Smith B; Balkrishnan R
    Paediatr Drugs; 2003; 5(1):11-23. PubMed ID: 12513103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin: clinical use.
    Truong DD; Jost WH
    Parkinsonism Relat Disord; 2006 Sep; 12(6):331-55. PubMed ID: 16870487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of botulinum neurotoxin for spasticity].
    Mukai Y; Kaji R
    Brain Nerve; 2008 Dec; 60(12):1421-6. PubMed ID: 19110753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of botulinum toxin in neurological indications.
    Ward AB; Molenaers G; Colosimo C; Berardelli A
    Eur J Neurol; 2006 Dec; 13 Suppl 4():20-6. PubMed ID: 17112346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin (BoNT) and back pain.
    Porta M; Maggioni G
    J Neurol; 2004 Feb; 251 Suppl 1():I15-8. PubMed ID: 14991338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence on botulinum toxin in selected disorders.
    Zakin E; Simpson D
    Toxicon; 2018 Jun; 147():134-140. PubMed ID: 29408357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Botulinum Toxin in Orofacial Clinical Practice.
    Serrera-Figallo MA; Ruiz-de-León-Hernández G; Torres-Lagares D; Castro-Araya A; Torres-Ferrerosa O; Hernández-Pacheco E; Gutierrez-Perez JL
    Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32053883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin in movement disorders.
    Papapetropoulos S; Singer C
    Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innervation zone targeted botulinum toxin injections.
    Kaymak B; Kara M; Yağiz On A; Soylu AR; Özçakar L
    Eur J Phys Rehabil Med; 2018 Feb; 54(1):100-109. PubMed ID: 28264545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin treatment of secretory disorders.
    Naumann M; Jost W
    Mov Disord; 2004 Mar; 19 Suppl 8():S137-41. PubMed ID: 15027066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.